Michelle Goldsworthy

Michelle Goldsworthy

Auto-generated profile, based on publicly available information

Michelle Goldsworthy

Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 February 2005 in Diabetologia
Verified
Journal Article
Closed access
PDF file
ATA. A. Toye
A. A. Toye
JLJ. D. Lippiat
J. D. Lippiat
PPP. Proks
P. Proks
KSK. Shimomura
K. Shimomura
LBL. Bentley
L. Bentley
RCR. D. Cox
R. D. Cox

15 November 2019 in Nature Communications
Verified
Journal Article
Open access
SHSarah A. Howles
Sarah A. Howles
AWAkira Wiberg
Akira Wiberg
MGMichelle Goldsworthy
Michelle Goldsworthy
ABAsha L. Bayliss
Asha L. Bayliss
AGAnna K. Gluck
Anna K. Gluck
DFDominic Furniss
Dominic Furniss
Kidney stone disease (nephrolithiasis) is a major clinical and economic health burden with a heritability of ~45–60%. We present genome-wide association studies in British and Japanese populations and a trans-ethnic meta-analysis that include 12,123 cases and 417,378 controls, and identify 20 nephrolithiasis-associated loci, seven of which are previously unreported. A CYP24A1 locus is predicted to affect vitamin D metabolism and five loci, DGKD, DGKH, WDR72, GPIC1, and BCR, are predicted to influence calcium-sensing receptor (CaSR) signaling. In a validation cohort of only nephrolithiasis patients, the CYP24A1-associated locus correlates with serum calcium concentration and a number of nephrolithiasis episodes while the DGKD-associated locus correlates with urinary calcium excretion. In vitro, DGKD knockdown impairs CaSR-signal transduction, an effect rectified with the calcimimetic cinacalcet. Our findings indicate that studies of genotype-guided precision-medicine approaches, including withholding vitamin D supplementation and targeting vitamin D activation or CaSR-signaling pathways in patients with recurrent kidney stones, are warranted.

18 August 2016 in Nature Communications
Verified
Journal Article
Open access
PDF file
PPPaul Keith Potter
Paul Keith Potter
MBMichael R Bowl
Michael R Bowl
PJPrashanthini Jeyarajan
Prashanthini Jeyarajan
LWLaura Wisby
Laura Wisby
ABAndrew Blease
Andrew Blease
SBSteve D M Brown
Steve D M Brown
Determining the genetic bases of age-related disease remains a major challenge requiring a spectrum of approaches from human and clinical genetics to the utilization of model organism studies. Here we report a large-scale genetic screen in mice employing a phenotype-driven discovery platform to identify mutations resulting in age-related disease, both late-onset and progressive. We have utilizedN-ethyl-N-nitrosourea mutagenesis to generate pedigrees of mutagenized mice that were subject to recurrent screens for mutant phenotypes as the mice aged. In total, we identify 105 distinct mutant lines from 157 pedigrees analysed, out of which 27 are late-onset phenotypes across a range of physiological systems. Using whole-genome sequencing we uncover the underlying genes for 44 of these mutant phenotypes, including 12 late-onset phenotypes. These genes reveal a number of novel pathways involved with age-related disease. We illustrate our findings by the recovery and characterization of a novel mouse model of age-related hearing loss.

3 October 2023 in Journal of the American Society of Nephrology
Verified
Journal Article
Open access
CLCatherine E. Lovegrove
Catherine E. Lovegrove
JBJelena Bešević
Jelena Bešević
AWAkira Wiberg
Akira Wiberg
BLBen Lacey
Ben Lacey
TLThomas Littlejohns
Thomas Littlejohns
SHSarah A. Howles
Sarah A. Howles
Significance Statement: Kidney stone disease is a common disorder with poorly understood pathophysiology. Observational and genetic studies indicate that adiposity is associated with an increased risk of kidney stone disease. However, the relative contribution of general and central adipose depots and the mechanisms by which effects of adiposity on kidney stone disease are mediated have not been defined. Using conventional and genetic epidemiological techniques, we demonstrate that general and central adiposity are independently associated with kidney stone disease. In addition, one mechanism by which central adiposity increases risk of kidney stone disease is by increasing serum calcium concentration. Therapies targeting adipose depots may affect calcium homeostasis and help to prevent kidney stone disease. Background: Kidney stone disease affects approximately 10% of individuals in their lifetime and is frequently recurrent. The disease is linked to obesity, but the mechanisms mediating this association are uncertain. Methods: Associations of adiposity and incident kidney stone disease were assessed in the UK Biobank over a mean of 11.6 years/person. Genome-wide association studies and Mendelian randomization (MR) analyses were undertaken in the UK Biobank, FinnGen, and in meta-analyzed cohorts to identify factors that affect kidney stone disease risk. Results: Observational analyses on UK Biobank data demonstrated that increasing central and general adiposity is independently associated with incident kidney stone formation. Multivariable MR, using meta-analyzed UK Biobank and FinnGen data, established that risk of kidney stone disease increases by approximately 21% per one standard deviation increase in body mass index (BMI, a marker of general adiposity) independent of waist-to-hip ratio (WHR, a marker of central adiposity) and approximately 24% per one standard deviation increase of WHR independent of BMI. Genetic analyses indicate that higher WHR, but not higher BMI, increases risk of kidney stone disease by elevating adjusted serum calcium concentrations (β=0.12 mmol/L); WHR mediates 12%–15% of its effect on kidney stone risk in this way. Conclusions: Our study indicates that visceral adipose depots elevate serum calcium concentrations, resulting in increased risk of kidney stone disease. These findings highlight the importance of weight loss in individuals with recurrent kidney stones and suggest that therapies targeting adipose depots may affect calcium homeostasis and contribute to prevention of kidney stone disease.

18 March 2016 in Diabetes
Verified
Journal Article
Open access
PDF file
SCStephan Collins
Stephan Collins
HDHyun Woong Do
Hyun Woong Do
BHBenoit Hastoy
Benoit Hastoy
AHAlison Hugill
Alison Hugill
JAJulie Adam
Julie Adam
PRPatrik Rorsman
Patrik Rorsman
The transcription factor Sox4 has been proposed to underlie the increased type 2 diabetes risk linked to an intronic single nucleotide polymorphism in CDKAL1. In a mouse model expressing a mutant form of Sox4, glucose-induced insulin secretion is reduced by 40% despite normal intracellular Ca2+ signaling and depolarization-evoked exocytosis. This paradox is explained by a fourfold increase in kiss-and-run exocytosis (as determined by single-granule exocytosis measurements) in which the fusion pore connecting the granule lumen to the exterior expands to a diameter of only 2 nm, which does not allow the exit of insulin. Microarray analysis indicated that this correlated with an increased expression of the exocytosis-regulating protein Stxbp6. In a large collection of human islet preparations (n = 63), STXBP6 expression and glucose-induced insulin secretion correlated positively and negatively with SOX4 expression, respectively. Overexpression of SOX4 in the human insulin–secreting cell EndoC-βH2 interfered with granule emptying and inhibited hormone release, the latter effect reversed by silencing STXBP6. These data suggest that increased SOX4 expression inhibits insulin secretion and increased diabetes risk by the upregulation of STXBP6 and an increase in kiss-and-run exocytosis at the expense of full fusion. We propose that pharmacological interventions promoting fusion pore expansion may be effective in diabetes therapy.

1 October 2002 in Mammalian Genome
Verified
Journal Article
Closed access
PDF file
THTertius A. Hough
Tertius A. Hough
PNPatrick M. Nolan
Patrick M. Nolan
VTVicky Tsipouri
Vicky Tsipouri
ATAyo A. Toye
Ayo A. Toye
IGIan C. Gray
Ian C. Gray
AHA. Jacqueline Hunter
A. Jacqueline Hunter